Literature DB >> 15643981

Canadian society of transplantation consensus workshop on cytomegalovirus management in solid organ transplantation final report.

Jutta K Preiksaitis1, Daniel C Brennan, Jay Fishman, Upton Allen.   

Abstract

The Canadian Society of Transplantation sponsored a Cytomegalovirus (CMV) Consensus Working Group that met on March 19, 2003. The objectives of this group were to determine the current burden of CMV-associated disease in the setting of solid organ transplantation in Canada, make recommendations regarding optimal strategies for the diagnosis, treatment and prevention of CMV infection and disease, highlight gaps in knowledge and outline priorities for research and other initiatives that might further reduce the burden of CMV-associated effects in this setting. This report summarizes the recommendations of the working group including ratings of the strength of evidence supporting the recommendations.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15643981     DOI: 10.1111/j.1600-6143.2004.00692.x

Source DB:  PubMed          Journal:  Am J Transplant        ISSN: 1600-6135            Impact factor:   8.086


  43 in total

1.  Introduction: disease overview and risk factors.

Authors: 
Journal:  P T       Date:  2010-03

Review 2.  Polyomavirus BK infection in blood and marrow transplant recipients.

Authors:  L K Dropulic; R J Jones
Journal:  Bone Marrow Transplant       Date:  2007-10-22       Impact factor: 5.483

3.  Canadian Cardiovascular Society Consensus Conference update on cardiac transplantation 2008: Executive Summary.

Authors:  H Haddad; D Isaac; J F Legare; P Pflugfelder; P Hendry; M Chan; B Cantin; N Giannetti; S Zieroth; M White; W Warnica; K Doucette; V Rao; A Dipchand; M Cantarovich; W Kostuk; R Cecere; E Charbonneau; H Ross; N Poirier
Journal:  Can J Cardiol       Date:  2009-04       Impact factor: 5.223

4.  Cytomegalovirus-Responsive CD8+ T Cells Expand After Solid Organ Transplantation in the Absence of CMV Disease.

Authors:  L E Higdon; J Trofe-Clark; S Liu; K B Margulies; M K Sahoo; E Blumberg; B A Pinsky; J S Maltzman
Journal:  Am J Transplant       Date:  2017-03-13       Impact factor: 8.086

Review 5.  Colonic perforation due to severe cytomegalovirus disease in granulomatosis with polyangiitis after immunosuppression.

Authors:  Alessandra Soriano; Nazareno Smerieri; Stefano Bonilauri; Loredana De Marco; Alberto Cavazza; Carlo Salvarani
Journal:  Clin Rheumatol       Date:  2018-01-04       Impact factor: 2.980

6.  Population pharmacokinetics of ganciclovir following administration of valganciclovir in paediatric renal transplant patients.

Authors:  Wei Zhao; Véronique Baudouin; Daolun Zhang; Georges Deschênes; Chantal Le Guellec; Evelyne Jacqz-Aigrain
Journal:  Clin Pharmacokinet       Date:  2009       Impact factor: 6.447

7.  Human Cytomegalovirus (HCMV) - Revised.

Authors:  Volkmar Schottstedt; Johannes Blümel; Reinhard Burger; Christian Drosten; Albrecht Gröner; Lutz Gürtler; Margarethe Heiden; Martin Hildebrandt; Bernd Jansen; Thomas Montag-Lessing; Ruth Offergeld; Georg Pauli; Rainer Seitz; Uwe Schlenkrich; Johanna Strobel; Hannelore Willkommen; Carl-Heinz Wirsing von König
Journal:  Transfus Med Hemother       Date:  2010-11-17       Impact factor: 3.747

Review 8.  Monitoring and managing viral infections in pediatric renal transplant recipients.

Authors:  Patrizia Comoli; Fabrizio Ginevri
Journal:  Pediatr Nephrol       Date:  2011-02-26       Impact factor: 3.714

9.  Differential CMV-specific CD8+ effector T cell responses in the lung allograft predominate over the blood during human primary infection.

Authors:  Matthew R Pipeling; Erin E West; Christine M Osborne; Amanda B Whitlock; Lesia K Dropulic; Matthew H Willett; Michael Forman; Alexandra Valsamakis; Jonathan B Orens; David R Moller; Noah Lechtzin; Stephen A Migueles; Mark Connors; John F McDyer
Journal:  J Immunol       Date:  2008-07-01       Impact factor: 5.422

10.  Long-term outcomes of pre-emptive valganciclovir compared with valacyclovir prophylaxis for prevention of cytomegalovirus in renal transplantation.

Authors:  Tomas Reischig; Petra Hribova; Pavel Jindra; Ondrej Hes; Mirko Bouda; Vladislav Treska; Ondrej Viklicky
Journal:  J Am Soc Nephrol       Date:  2012-08-23       Impact factor: 10.121

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.